Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years.
about
Survivorship in Non-Small Cell Lung Cancer: Challenges Faced and Steps Forward.Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversiesCD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients.Comparison of relative forced expiratory volume of one second with dynamic magnetic resonance imaging parameters in healthy subjects and patients with lung cancer
P2860
Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Persistent excess mortality fr ...... r, disease-free after 5 years.
@ast
Persistent excess mortality fr ...... r, disease-free after 5 years.
@en
type
label
Persistent excess mortality fr ...... r, disease-free after 5 years.
@ast
Persistent excess mortality fr ...... r, disease-free after 5 years.
@en
prefLabel
Persistent excess mortality fr ...... r, disease-free after 5 years.
@ast
Persistent excess mortality fr ...... r, disease-free after 5 years.
@en
P2093
P2860
P356
P1476
Persistent excess mortality fr ...... r, disease-free after 5 years.
@en
P2093
Accordini S
Pedrazzani C
de Manzoni G
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600991
P407
P577
2003-06-01T00:00:00Z
P5875
P6179
1005851003